Ftse Mib
36.099,20
-1,02%
DAX
21.370,58
-1,57%
S&P 500
6.040,53
0,00%
NASDAQ
19.627,44
0,00%
Bitcoin
94.603,24
-3,17%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ IVERIC bio Inc (ISEE) IVERIC bio Inc (ISEE) Notizie

ISEE

IVERIC bio (ISEE)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ISEE
DataOraFonteTitoloSimboloCompagnia
14/02/202414:49Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ISEEIVERIC bio Inc
21/07/202314:30Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:ISEEIVERIC bio Inc
18/07/202306:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ISEEIVERIC bio Inc
13/07/202320:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ISEEIVERIC bio Inc
12/07/202301:00PR Newswire (US)Astellas Completes Acquisition of Iveric BioNASDAQ:ISEEIVERIC bio Inc
11/07/202316:13Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ISEEIVERIC bio Inc
11/07/202316:01Edgar (US Regulatory)Form POSASR - Post-effective Amendment to an automatic shelf registration statementNASDAQ:ISEEIVERIC bio Inc
11/07/202315:57Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:ISEEIVERIC bio Inc
11/07/202315:22Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ISEEIVERIC bio Inc
05/07/202322:05Business WireIveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ISEEIVERIC bio Inc
29/06/202322:58Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ISEEIVERIC bio Inc
29/06/202322:57Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ISEEIVERIC bio Inc
29/06/202300:24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ISEEIVERIC bio Inc
05/06/202314:54Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (definitive) (defm14a)NASDAQ:ISEEIVERIC bio Inc
02/06/202322:28Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:ISEEIVERIC bio Inc
17/05/202322:07Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ISEEIVERIC bio Inc
10/05/202313:53Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ISEEIVERIC bio Inc
01/05/202313:03Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ISEEIVERIC bio Inc
01/05/202302:57Dow Jones NewsAstellas Pharma to Buy Iveric Bio for About $5.9 BillionNASDAQ:ISEEIVERIC bio Inc
01/05/202301:00Business WireAstellas Enters Into Definitive Agreement to Acquire Iveric BioNASDAQ:ISEEIVERIC bio Inc
01/05/202301:00PR Newswire (US)Astellas Enters into Definitive Agreement to Acquire Iveric BioNASDAQ:ISEEIVERIC bio Inc
23/04/202323:15Business WireIveric Bio Announces New Functional Vision Loss Reduction Data from Avacincaptad Pegol GATHER Trials Presented at ARVO Annual MeetingNASDAQ:ISEEIVERIC bio Inc
06/04/202322:25Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:ISEEIVERIC bio Inc
05/04/202322:12Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ISEEIVERIC bio Inc
01/03/202322:18Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ISEEIVERIC bio Inc
01/03/202312:32Business WireIveric Bio Reports Fourth Quarter and Full Year 2022 Operational Highlights and Financial ResultsNASDAQ:ISEEIVERIC bio Inc
01/03/202312:30Business WireIveric Bio Announces Vision Loss Reduction Data in Geographic Atrophy from Avacincaptad Pegol GATHER TrialsNASDAQ:ISEEIVERIC bio Inc
28/02/202314:00Business WireIveric Bio to Present at the Cowen 43rd Annual Health Care ConferenceNASDAQ:ISEEIVERIC bio Inc
22/02/202314:00Business WireIveric Bio to Report Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call on Wednesday, March 1, 2023NASDAQ:ISEEIVERIC bio Inc
17/02/202316:54Dow Jones NewsIveric Bio Shares Rise 16% After FDA Accepts New Drug App for Avacincaptad PegolNASDAQ:ISEEIVERIC bio Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ISEE

La tua Cronologia

BIT
STLAM
Stellantis NV
BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
STMMI
ST Microelectronics
BIT
ENEL
Enel
BIT
G
Generali
BIT
RACE
Ferrari NV
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
ENI
Eni
BIT
NEXI
Nexi S.p.A
BIT
SPM
Saipem
BIT
LDO
Leonardo
BIT
PRY
Prysmian
BIT
PIRC
Pirelli & C
BIT
BPE
Bper Banca
BIT
BAMI
Banco BPM
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci